Why did 1332.HK stock drop so sharply after hours?

The after-hours drop to **HK$0.109** reflects heavy selling and a **31,270,000** share session that overwhelmed typical liquidity. Weak short-term ratios, negative EPS, and investor concern about working capital likely triggered the move.

What is Meyka AI's view and score for 1332.HK stock?

Meyka AI rates 1332.HK with a score out of 100 at **60.15** (Grade B, Suggestion: HOLD). The grade balances sector metrics, financial growth, and forecasts; it is informational and not investment advice.

What price targets and upside does the forecast show for 1332.HK stock?

Meyka AI's forecast model projects **HK$0.125294** yearly and **HK$0.27** quarterly. Versus the current **HK$0.109**, the yearly implies **~14.95%** upside and the quarterly implies **~147.70%** in a recovery case.

What key indicators should traders watch for 1332.HK stock?

Monitor daily volume relative to the **5,143,099** average, improvements in current ratio above **1.0**, receivables aging, and RSI moving above **50**. Confirming lower volatility and steady cashflow are also critical.

HK Stocks

After-hours top loser: 1332.HK Touyun Biotech (HKSE) down 58%, liquidity flag

ByDanny Kontos January 26, 2026January 26, 2026

1332.HK stock plunged sharply after hours on 26 Jan 2026, sliding to HK$0.109 on heavy turnover. The share price fell 58.08% from the previous close, driven by a 31,270,000 share print that dwarfed the 50-day average. This move made Touyun Biotech Group Limited one of the session’s top losers on the HKSE in Hong Kong and raises near-term liquidity and solvency questions for investors watching the packaging and biotech segments.